Pendapatan perusahaan HeartFlow Inc (HTFL)

Heartflow Inc (HTFL) sales volume history demonstrates the effectiveness of cloud AI that creates 3D blood flow models to replace invasive procedures, with the current value standing at 0.21. Revolutionary ischemia diagnostic platforms are driving rapid commercial growth and reducing mortality rates. The application of computer modeling supports ESG compliance by reducing the consumption of medical reagents and plastics.

HTFL heartflow.com: Dodolan perusahaan ing interval 09.08.2025 - 13.11.2026

Rincian metrik komprehensif lan analitis HeartFlow, Inc. (HTFL)

- rega saham lan target rega konsensus:

Bagan kutipan heartflow.com|HTFL - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar HeartFlow, Inc.|HTFL - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Aset Bersih saben Saham HeartFlow|HTFL - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Aset Bersih heartflow.com|HTFL - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Heartflow Inc|HTFL - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal HeartFlow Inc|HTFL - Utang perusahaan|Rasio utang marang nilai buku HeartFlow, Inc.|HTFL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan HeartFlow|Rasio jangkoan perantara heartflow.com

- data bathi bisnis lan rasio investasi:

HTFL - Penghasilan resik|Bathi resik mangsa ngarep Heartflow Inc|HTFL - Pangali P/E|Rasio rega marang bathi sing dikarepake Heartflow Inc|HTFL - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan HeartFlow, Inc.|HTFL - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku HeartFlow|HTFL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan heartflow.com|HTFL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Heartflow Inc

- rincian pendapatan lan dodolan emiten:

HTFL - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan HeartFlow, Inc.|HTFL - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake HeartFlow, Inc.

Analisis komprehensif perusahaan:HeartFlow Medical HTFL

A comparative analysis of this asset requires benchmarking revenue dynamics against the US industry cycle, where extremes are indexed through the lens of market liquidity. This metric captures daily cash inflows from product sales, which for Heartflow Inc (HTFL) signifies the scaling of cloud licenses with high operating leverage; consequently, the company's growth in sales volume directly confirms the effectiveness of the commercial implementation of AI diagnostics.

Pesaing wigati

Regeneron Corp - Pendapatan tahunan perusahaan|Pendapatan perusahaan iRhythm Technologies (IRTC)|Pendapatan perusahaan LNTH (lantheus.com)|Pendapatan perusahaan Mineralys Therapeutics, Inc. MLYS|Kestra Medical Technologies, Inc. (KMTS) - Total pendapatan perusahaan|ESPR: Dodolan perusahaan|Amarin Pharma (AMRN) - Dodolan perusahaan|AVR (anteristech.com) - Dodolan perusahaan|Tenaya Therapeutics, Inc. - Pendapatan dodolan perusahaan|CVRX (CVRx) - Pendapatan lan volume dodolan|Milestone Pharmaceuticals, Inc. (MIST) - Pendapatan reged perusahaan|Pendapatan perusahaan Cardiol Therapeutics (CRDL)|HeartBeam Corporation - Volume dodolan perusahaan|Pendapatan lan volume dodolan TENX (Tenax Therapeutics)|ADGM - Dodolan perusahaan|BioCardia - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan VTAK (Catheter Precision Inc)|ABIO (arcabio.com) - Dodolan perusahaan|ACST: Total dodolan perusahaan|AVTE (Aerovate Therapeutics) - Pendapatan lan volume dodolan|Verve - Pendapatan tahunan perusahaan|Pendapatan perusahaan Windtree Therapeutics (WINT)